Clay Thorp's Net Worth
Clay Thorp's net worth is estimated to be at least $49,492,895.11 as of 12/24/2024. CoreStreet's estimation of Clay Thorp's net worth is based on their sale of stock and current holding of stock.
Clay Thorp is Director at Clearside Biomedical Inc. They have executed at least 38 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,000 units of CLSD stock on 09/25/2023. Their biggest sale was on 05/30/2018 when they sold 800,000 units of G1 Therapeutics Inc stock for $38,400,000.00. They typically trade 4 times per year.
Total value of insider buys:
- $2,176,048.52
Total value of insider sells:
- $47,316,846.59
Most recent insider trade:
- Sept. 25, 2023
Clay Thorp's Insider Trading History
| Clearside Biomedical Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 25, 2023 | Director | 10,000 | $0.86 | Buy | $8,600.00 |
Dec. 21, 2022 | Director | 14,000 | $1.02 | Buy | $14,280.00 |
Feb. 10, 2021 | Director | 32,873 | $4.43 | Sell | $145,627.39 |
Dec. 6, 2018 | Director | 8,000 | $1.36 | Buy | $10,880.00 |
May 18, 2018 | Director | 161,139 | $13.08 | Sell | $2,107,698.12 |
Dec. 7, 2017 | Director | 5,000 | $6.13 | Sell | $30,650.00 |
Dec. 5, 2017 | Director | 15,000 | $6.37 | Sell | $95,550.00 |
Nov. 16, 2017 | Director | 35,000 | $7.00 | Sell | $245,000.00 |
Nov. 14, 2017 | Director | 15,000 | $7.02 | Sell | $105,300.00 |
Oct. 5, 2017 | Director | 35,000 | $8.57 | Sell | $299,950.00 |
Sept. 15, 2017 | Director | 24,500 | $7.52 | Sell | $184,240.00 |
Sept. 14, 2017 | Director | 6,000 | $7.52 | Sell | $45,120.00 |
Sept. 13, 2017 | Director | 8,500 | $7.49 | Sell | $63,665.00 |
Aug. 9, 2017 | Director | 24,500 | $7.57 | Sell | $185,465.00 |
Aug. 8, 2017 | Director | 5,000 | $7.98 | Sell | $39,900.00 |
Aug. 7, 2017 | Director | 4,500 | $8.02 | Sell | $36,090.00 |
May 19, 2017 | Director | 24,000 | $8.36 | Sell | $200,640.00 |
May 17, 2017 | Director | 44,485 | $8.63 | Sell | $383,905.55 |
May 16, 2017 | Director | 9,544 | $8.61 | Sell | $82,173.84 |
May 15, 2017 | Director | 15,941 | $8.94 | Sell | $142,512.54 |
April 19, 2017 | Director | 68,485 | $7.46 | Sell | $510,898.10 |
April 18, 2017 | Director | 44,455 | $7.48 | Sell | $332,523.40 |
April 17, 2017 | Director | 22,000 | $7.43 | Sell | $163,460.00 |
March 16, 2017 | Director | 68,485 | $6.56 | Sell | $449,261.60 |
Feb. 22, 2017 | Director | 27,000 | $7.55 | Sell | $203,850.00 |
Feb. 17, 2017 | Director | 41,485 | $7.60 | Sell | $315,286.00 |
Jan. 20, 2017 | Director | 68,485 | $8.53 | Sell | $584,177.05 |
June 7, 2016 | Director | 138 | $7.00 | Sell | $966.00 |
| Vigil Neuroscience Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 16, 2022 | Director | 21,802 | $2.76 | Buy | $60,173.52 |
March 28, 2022 | Director | 3,000 | $7.20 | Buy | $21,600.00 |
| PhaseBio Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 18, 2021 | Director | 10,000 | $3.00 | Buy | $30,000.00 |
Nov. 24, 2020 | Director | 5,000 | $3.60 | Buy | $18,000.00 |
July 1, 2019 | Director | 2,908 | $14.00 | Sell | $40,712.00 |
June 18, 2019 | Director | 400 | $14.00 | Sell | $5,600.00 |
Dec. 4, 2018 | Director | 4,000 | $3.13 | Buy | $12,520.00 |
| G1 Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 30, 2018 | Major Shareholder | 800,000 | $48.00 | Sell | $38,400,000.00 |
May 23, 2018 | Major Shareholder | 37,500 | $51.11 | Sell | $1,916,625.00 |
May 22, 2017 | Major Shareholder | 133,333 | $15.00 | Buy | $1,999,995.00 |